Search
for
Sort by
Research 31–60 of 1000+
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The PDGF/PDGFR pathway as a drug target
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence
- Emerging role of ILK and ELMO2 in the integration of adhesion and migration pathways
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Drug-induced scarring and permanent alopecia
- Botryococcus terribilis Ethanol Extract Exerts Anti-inflammatory Effects on Murine RAW264 Cells
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Drug-induced hair pigmentation: Clinical perspectives and updates
- LPA-producing enzyme PA-PLA<sub>1</sub>α regulates hair follicle development by modulating EGFR signalling
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- The urine as a diagnostic key for a homozygous EGFR mutation
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Management of Toxicities of Targeted Therapies
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies